Associations of clinical characteristics and treatment regimens with the duration of viral RNA shedding in patients with COVID-19
Objective: The novel coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global pandemic, but the factors influencing viral RNA shedding, which would help inform optimal control strategies, remain unclear. Methods: The clinical co...
Main Authors: | Xudan Chen, Baoyi Zhu, Wenxin Hong, Jianwen Zeng, Xi He, Jingfeng Chen, Haipeng Zheng, Shuang Qiu, Ying Deng, Juliana C.N. Chan, Jian Wang, Yuying Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971220305269 |
Similar Items
-
Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan
by: Chien-Yu Cheng, et al.
Published: (2020-06-01) -
Determination of lopinavir/ritonavir concentrations in four different oral solutions for the application of antiretroviral therapy in very young, HIV-1-infected children
by: Nils von Hentig, et al.
Published: (2021-05-01) -
COVID-19 Hastalarında Lopinavir/Ritonavir ve Favipravir Deneyimi
by: Şule Özdemir, et al.
Published: (2020-12-01) -
Antiviral treatment could not provide clinical benefit in management of mild COVID-19: A Retrospective Experience from Field hospital
by: Natsuda Aumpan, et al.
Published: (2021-09-01) -
Role of adjunctive treatment strategies in COVID-19 and a review of international and national clinical guidelines
by: Xinni Xu, et al.
Published: (2020-05-01)